Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 1/2 1

Status

Completed 37Active not recruiting 28Recruiting 27Terminated 12Unknown 8Withdrawn 5Not yet recruiting 3Suspended 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2Gynecologic 1

Conditions

Sarcoma 2Uterine Cervical Neoplasms 1Rectal Neoplasms 1Esophageal Neoplasms 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Proton Therapy × Clear all
NCT01034566 2021-06-10

Proton Beam Radiation Therapy in Treating Patients With Retroperitoneal Sarcoma

Abramson Cancer Center at Penn Medicine

Phase NA Withdrawn
Sarcoma

Sarcoma

NCT01019278 2020-04-03

Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph Nodes

Abramson Cancer Center at Penn Medicine

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Neoplasms

NCT03234842 2018-12-21

ES01

University of Florida

Phase 2 Withdrawn
Gastrointestinal

Esophageal Neoplasms

NCT00881595 2017-02-10

SA02

University of Florida

Phase 2 Withdrawn
Sarcoma

Sarcoma

NCT00503932 2012-03-22

Proton Therapy With Capecitabine for Rectal Cancer

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡